Flex Pharma CEO David and's 2023 pay falls 42% to $545K
Flex Pharma reports 2023 executive compensation
By ExecPay News
Published: November 1, 2024
Flex Pharma reported fiscal year 2023 executive compensation information on November 1, 2024.
In 2023, two executives at Flex Pharma received on average a compensation package of $450K, a 37% decrease compared to previous year.
Average pay of disclosed executives at Flex Pharma
David J. Arthur President and, Chief Executive Officer, received $545K in total, which decreased by 42% compared to 2022. 92% of and's compensation, or $500K, was in salary. and also received $31K in stock awards and $13K in other compensation.
Mark J. Rosenblum, Chief Financial Officer, received a compensation package of $356K, which decreased by 28% compared to previous year. 93% of the compensation package, or $330K, was in salary.
Related executives
You may also like
Source: SEC filing on November 1, 2024.